Aberrant Silencing of the CpG Island-Containing Human O⁶-Methylguanine DNA Methyltransferase Gene Is Associated with the Loss of Nucleosome-Like Positioning

REFERENCES

• Antequera, F., and A. Bird. 1993. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90:11995–11999.
   PubMed Web of Science ®Google Scholar
• Antequera, F., J. Boyes, and A. Bird. 1990. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503–514.
   PubMed Web of Science ®Google Scholar
• Aparicio, O. M., and D. E. Gottschling. 1994. Overcoming telomeric silencing: a trans-activator competes to establish gene expression in a cell cycledependent way. Genes Dev. 8:1136–1146.
   Google Scholar
• Cockell, M., D. Rhodes, and A. Klug. 1983. Location of primary sites of micrococcal nuclease cleavage on the nucleosome core. J. Mol. Biol. 170:423–446.
   PubMed Web of Science ®Google Scholar
• Costello, J. F., B. W. Futscher, K. Tano, D. M. Graunke, and R. O. Pieper. 1994. Graded methylation in the promoter and body of O6-methylguanine- DNA-methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J. Biol. Chem. 269:17228–17237.
   PubMed Web of Science ®Google Scholar
• Costello, J. F., B. W. Futscher, R. A. Kroes, and R. O. Pieper. 1994. Methylationrelated chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O6-methylguanine-DNA-methyltransferase gene in human glioma cell lines. Mol. Cell. Biol. 14:6515–6521.
   PubMedGoogle Scholar
• Drew, H. R. 1984. Structural specificities of five commonly used DNA nucleases. J. Mol. Biol. 176:535–557.
   PubMed Web of Science ®Google Scholar
• Erickson, L. C. 1991. The role of O-6 methylguanine DNA methyltransferase (MGMT) in drug resistance and strategies for its inhibition. Semin. Cancer Biol. 2:257–265.
   PubMedGoogle Scholar
• Feinberg, A., and B. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266–267.
   PubMed Web of Science ®Google Scholar
• Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261–282.
   PubMed Web of Science ®Google Scholar
• Godde, J. S., S. U. Kass, M. C. Hirst, and A. P. Wolffe. 1996. Nucleosome assembly on methylated CGG triplet repeats in the fragile X mental retardation gene 1 promoter. J. Biol. Chem. 271:24325–24328.
   PubMed Web of Science ®Google Scholar
• Gross, D. S., and W. T. Garrard. 1988. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57:159–197.
   PubMed Web of Science ®Google Scholar
• Harris, L. C., P. M. Potter, K. Tano, S. Shiota, S. Mitra, and T. P. Brent. 1991. Characterization of the promoter region of the human O6-methylguanine-DNA-methyltransferase gene. Nucleic Acids Res. 19:6163–6167.
   PubMed Web of Science ®Google Scholar
• Herman, J. G., F. Latif, Y. Weng, M. I. Lerman, B. Zbar, S. Liu, D. Samid, D.-S. R. Duan, J. R. Gnarra, W. M. Linehan, and S. B. Baylin. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700–9704.
   PubMed Web of Science ®Google Scholar
• Hershkovitz, M., and A. D. Riggs. 1995. Metaphase chromosome analysis by ligation-mediated PCR: heritable chromatin structure and a comparison of active and inactive X chromosomes. Proc. Natl. Acad. Sci. USA 92:2379–2383.
   PubMedGoogle Scholar
• Issa, J.-P. J., Y. L. Ottaviano, P. Celano, S. R. Hamilton, N. E. Davidson, and S. B. Baylin. 1994. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7:536–540.
   PubMed Web of Science ®Google Scholar
• Kass, S. U., J. P. Gaddard, and R. L. P. Adams. 1993. Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol. 13:7372–7379.
   PubMedGoogle Scholar
• Kass, S. U., N. Landsberger, and A. P. Wolffe. 1997. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7:157–165.
   PubMed Web of Science ®Google Scholar
• Kovesdi, I., R. Reichel, and J. R. Nevins. 1987. Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc. Natl. Acad. Sci. USA 84:2180–2184.
   PubMed Web of Science ®Google Scholar
• Lapidus, R. G., A. T. Ferguson, Y. L. Ottaviano, F. F. Parl, H. S. Smith, S. A. Weitzman, S. B. Baylin, J.-P. J. Issa, and N. E. Davidson. 1996. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin. Cancer Res. 2:805–810.
   PubMed Web of Science ®Google Scholar
• Larsen, F., G. Gundersen, R. Lopez, and H. Prydz. 1992. CpG islands as gene markers in the human genome. Genomics 13:1095–1107.
   PubMed Web of Science ®Google Scholar
• Lee, W.-H., R. A. Morton, J. I. Epstein, J. D. Brooks, P. A. Campbell, G. S. Bova, W.-S. Hseih, W. B. Isaacs, and W. G. Nelson. 1994. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 91:11733–11737.
   PubMed Web of Science ®Google Scholar
• Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282–2292.
   PubMed Web of Science ®Google Scholar
• Martinez-Balbas, M. A., A. Dey, S. K. Rabindran, K. Ozato, and C. Wu. 1995. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83:29–38.
   PubMed Web of Science ®Google Scholar
• Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
   PubMedGoogle Scholar
• McArthur, M., and J. O. Thomas. 1996. A preference of histone H1 for methylated DNA. EMBO J. 15:1705–1714.
   PubMedGoogle Scholar
• Meehan, R. R., J. D. Lewis, and A. Bird. 1992. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20:5085–5092.
   PubMed Web of Science ®Google Scholar
• Meehan, R. R., J. D. Lewis, S. McKay, E. L. Kleiner, and A. Bird. 1989. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499–507.
   PubMed Web of Science ®Google Scholar
• Miller, M. R., J. J. Castellot, and A. B. Pardee. 1978. A permeable animal cells preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry 17:1073–1080.
   PubMedGoogle Scholar
• Nan, X., R. R. Meehan, and A. Bird. 1993. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21:4886–4892.
   PubMed Web of Science ®Google Scholar
• Patel, S. A. Unpublished data.
   Google Scholar
• Pfeifer, G. P., and A. D. Riggs. 1991. Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permeabilized cells using DNaseI and ligation-mediated PCR. Genes Dev. 5:1102–1113.
   PubMedGoogle Scholar
• Pfeifer, G. P., R. L. Tanguay, S. D. Steigerwald, and A. D. Riggs. 1990. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev. 4:1277–1287.
   PubMed Web of Science ®Google Scholar
• Pieper, R. O., J. F. Costello, R. A. Kroes, B. W. Futscher, U. Marathi, and L. C. Erickson. 1991. Direct correlation between methylation status and expression status and expression of the human O6-methylguanine DNA methyltransferase gene. Cancer Commun. 3:241–253.
   PubMedGoogle Scholar
• Pieper, R. O., S. Patel, S. A. Ting, B. W. Futscher, and J. F. Costello. 1996. Methylation of transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J. Biol. Chem. 271:13916–13924.
   PubMed Web of Science ®Google Scholar
• Qian, X. C., and T. P. Brent. 1996. Delineation of CpG methylation sites in single copies of the MGMT gene promoter. Proc. Am. Assoc. Cancer Res. 37:536.
   Google Scholar
• Rideout, W. M., III, P. Eversole-Cire, C. H. Spruck III, C. M. Hustad, G. A. Coetzee, F. A. Gonzales, and P. A. Jones. 1994. Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation. Mol. Cell. Biol. 14:6143–6152.
   PubMed Web of Science ®Google Scholar
• Saluz, H. P., and J. P. Jost. 1987. A laboratory guide to sequencing, p. 11–36. Birkheuser, Boston, Mass.
   Google Scholar
• Tazi, J., and A. Bird. 1990. Alternative chromatin structure at CpG islands. Cell 60:909–920.
   PubMed Web of Science ®Google Scholar
• Thomas, G. H., and S. C. R. Elgin. 1988. Protein/DNA architecture of the DNaseI hypersensitive region of the Drosophila hsp26 promoter. EMBO J. 7:2191–2201.
   PubMedGoogle Scholar
• Watts, G. S., and B. W. Futscher. 1996. Hypomethylation of the O6-methylguanine DNA methyltransferase gene body eliminates its expression in a myeloma cell line. Proc. Am. Assoc. Cancer Res. 37:537.
   Google Scholar
• Wijnholds, J., and G. Philipsen. 1988. Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-induced apoVLDL II promoter in vivo. EMBO. J. 7:2757–2763.
   PubMedGoogle Scholar
• Zhang, L., and J. D. Gralla. 1989. In situ nucleoprotein structure at the SV40 major late promoter: melted and wrapped DNA flank the start site. Genes Dev. 3:1814–1822.
   PubMedGoogle Scholar
• Zion, M., D. Ben-Yehuda, A. Avraham, O. Cohen, M. Wetzler, D. Melloul, and Y. Ben-Neriah. 1994. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 91:10722–10726.
   PubMed Web of Science ®Google Scholar